FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)

Cardiovascular and Renal Drugs Advisory Committee

 

Hilton Washington DC North/Gaithersburg

Gaithersburg Maryland

SLIDES

April 25, 2006

The committee will  discuss new drug application (NDA) 21-359 Cellegesic™ (nitroglycerin [NTG] ointment), 0.4% intra-anal, Cellegy Pharmaceuticals, Inc., for the proposed indication of relief of pain associated with anal fissures

Sponsor Presentation – Cellegy Pharmaceuticals, Inc:

 

FDA Presentation:                

Up | AC Home Page

Page last updated May 9, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management